Works matching IS 08991987 AND DT 2022 AND VI 61 AND IP 8

Results: 9

Cover Image, Volume 61, Issue 8.
Published in:
Molecular Carcinogenesis, 2022, v. 61, n. 8, p. i, doi. 10.1002/mc.23450
By:
- Srivastava, Ritesh K.;
- Guroji, Purushotham;
- Jin, Lin;
- Mukhtar, M. Shahid;
- Athar, Mohammad
Publication type:
Article
Norcantharidin promotes cancer radiosensitization through Cullin1 neddylation‐mediated CDC6 protein degradation.
Published in:
Molecular Carcinogenesis, 2022, v. 61, n. 8, p. 812, doi. 10.1002/mc.23435
By:
- Deng, Tanggang;
- Zhu, Qianling;
- Xie, Lin;
- Liu, Youhong;
- Peng, Yuchong;
- Yin, Linglong;
- Gao, Yingxue;
- Cao, Tuoyu;
- Fu, Yuxin;
- Qi, Xuli;
- Zhang, Songwei;
- Peng, Yongbo;
- Hou, Youxiang;
- Li, Xiong
Publication type:
Article
Risk SNP‐mediated LINC01614 upregulation drives head and neck squamous cell carcinoma progression via PI3K/AKT signaling pathway.
Published in:
Molecular Carcinogenesis, 2022, v. 61, n. 8, p. 797, doi. 10.1002/mc.23422
By:
- Hou, Yaxuan;
- Zhou, Meng;
- Li, Yuncheng;
- Tian, Tingting;
- Sun, Xun;
- Chen, Mo;
- Xu, Wenmao;
- Lu, Meixia
Publication type:
Article
Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma.
Published in:
Molecular Carcinogenesis, 2022, v. 61, n. 8, p. 787, doi. 10.1002/mc.23421
By:
- Chen, Ping‐Tsung;
- Hsieh, Ching‐Chuan;
- Chen, Miao‐Fen
Publication type:
Article
Functional characterization and clinical significance of super‐enhancers in lung adenocarcinoma.
Published in:
Molecular Carcinogenesis, 2022, v. 61, n. 8, p. 776, doi. 10.1002/mc.23419
By:
- Jiang, Xiangxiang;
- Qin, Na;
- Hua, Tingting;
- Wei, Xiaoxia;
- Li, Yuancheng;
- Chen, Congcong;
- Gong, Linnan;
- Liu, Su;
- Wang, Cheng;
- Yin, Rong;
- Jiang, Yue;
- Dai, Juncheng;
- Xu, Lin;
- Shen, Hongbing;
- Ma, Hongxia
Publication type:
Article
CAF‐derived exosomes transmitted Gremlin‐1 promotes cancer progression and decreases the sensitivity of hepatoma cells to sorafenib.
Published in:
Molecular Carcinogenesis, 2022, v. 61, n. 8, p. 764, doi. 10.1002/mc.23416
By:
- Qin, Wei;
- Wang, Li;
- Tian, Huan;
- Wu, Xiaocai;
- Xiao, Cuicui;
- Pan, Yuhang;
- Fan, Mingming;
- Tai, Yan;
- Liu, Wei;
- Zhang, Qi;
- Yang, Yang
Publication type:
Article
Monocarboxylate transporter 1 is a novel target for breast cancer stem like‐cell inhibition by diallyl trisulfide.
Published in:
Molecular Carcinogenesis, 2022, v. 61, n. 8, p. 752, doi. 10.1002/mc.23415
By:
- Kim, Su‐Hyeong;
- Singh, Shivendra V.
Publication type:
Article
Combined inhibition of BET bromodomain and mTORC1/2 provides therapeutic advantage for rhabdomyosarcoma by switching cell death mechanism.
Published in:
Molecular Carcinogenesis, 2022, v. 61, n. 8, p. 737, doi. 10.1002/mc.23414
By:
- Srivastava, Ritesh K.;
- Guroji, Purushotham;
- Jin, Lin;
- Mukhtar, M. Shahid;
- Athar, Mohammad
Publication type:
Article
Issue Information ‐ Ed Board.
Published in:
Molecular Carcinogenesis, 2022, v. 61, n. 8, p. 735, doi. 10.1002/mc.23318
Publication type:
Article